Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Biomarkers for Predicting Mortality in Patients With Suspected Sepsis

NCT07521306 is registered in ClinicalTrials.gov with Antalya Training and Research Hospital as lead sponsor.

NCT NCT07521306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07521306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Biomarkers for Predicting Mortality in Patients With Suspected Sepsis
Lead sponsor
Antalya Training and Research Hospital
Phase
Observational
Overall status
Completed
Start date
May 1, 2023
Completion date
August 1, 2024
Enrollment
250 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biomarkers, mortality, sepsis